Skip to main content
Diabetes logoLink to Diabetes
. 2010 Jan;59(1):319. doi: 10.2337/db10-er01b

Errata

PMCID: PMC2797939

Gentile MT, Vecchione C, Marino G, Aretini A, Di Pardo A, Antenucci G, Maffei A, Cifelli G, Iorio L, Landolfi A, Frati G, Lembo G. Resistin impairs insulin-evoked vasodilation. Diabetes 2008;57:577–583

In the research design and methods subsection “Chronic resistin treatment” in the print version of the article listed above, the in vivo dose used in the experiment is reported incorrectly in the sentence “In some mice, resistin (1 μg/min) or vehicle was administered chronically for 28 days by osmotic minipumps implanted subcutaneously (Alzet).” The correct in vivo dose is 1 μg/day. The online version reflects these changes.


Articles from Diabetes are provided here courtesy of American Diabetes Association

RESOURCES